Cosmetic use of engineered postbiotics comprising bacteriocins and/or endolysins
AssigneeEligo Bioscience
InventorsAntoine Decrulle, Xavier Duportet
Life of this patent
Estimating the term…
Abstract
A method for the cosmetic caring of the skin and/or mucosa, comprising applying a postbiotic composition comprising at least one postbiotic and at least one bacteriocin and/or endolysin, wherein the postbiotic is preferably a bacterial lysate preferably obtained from bacteria heterologously expressing the at least one bacteriocin and/or endolysin and wherein the postbiotic and the at least one bacteriocin and/or endolysin have a synergistic effect in the cosmetic caring method.
Claims15
A method for killing unfavorable bacteria on a healthy skin and/or mucosa of a subject, comprising applying on said healthy skin and/or mucosa of said subject an engineered postbiotic composition comprising a microbial lysate and lysostaphin, wherein said lysostaphin is obtained from bacteria heterologously expressing said lysostaphin,
- wherein said microbial lysate and said lysostaphin have a synergistic effect in killing unfavorable bacteria on said healthy skin and/or mucosa of said subject.
A method for the care of sensitive, sensitized, fragile and/or weakened skin and/or mucosa, wherein an engineered postbiotic composition is applied on said sensitive, sensitized, fragile and/or weakened skin and/or mucosa,
- wherein said engineered postbiotic composition comprises a microbial lysate and lysostaphin, wherein said lysostaphin is obtained from bacteria heterologously expressing said lysostaphin,
- wherein said microbial lysate and said lysostaphin have a synergistic effect in killing unfavorable bacteria on said sensitive, sensitized, fragile and/or weakened skin and/or mucosa of said subject.
Dependencies are inferred from the claim text.